Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
17 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Swedish Orphan Biovitrum (Belgium) from Zaventem, company number BE0536217087, closed financial year 2025 with a result of € 985,683 after tax. For that financial year Swedish Orphan Biovitrum (Belgium) recorded revenue of € 8.3 million and equity of € 9.1 million. Compared with financial year 2024, the result moved from € 1.3 million to € 985,683. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.
€ 9.1 million
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 985,683
▼ 21% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 9.1 million.
People and assets in 2025
19.3
▲ 2.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 4.9 million
▲ 11% vs 2024
€ 255,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 255,729
▲ € 250,724 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 86,983
▲ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 7 days on average.
€ 1.5 million
▼ 9% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 6,106,443 | € 7,713,461 | € 8,199,077 | € 8,325,182 | ▲ 2% |
| Profit after taxes | € 547,192 | € 1,165,567 | € 1,255,251 | € 985,683 | ▼ 21% |
| Equity | € 5,739,658 | € 6,905,224 | € 8,160,476 | € 9,146,158 | ▲ 12% |
| Total debts | € 1,540,953 | € 1,926,117 | € 1,998,542 | € 1,825,191 | ▼ 9% |
| Retained profit | € 5,721,108 | € 6,886,674 | € 8,141,926 | € 9,127,608 | ▲ 12% |
| Balance sheet total | € 7,280,611 | € 8,831,341 | € 10,159,018 | € 10,971,349 | ▲ 8% |
| Employees (FTE) | 16.4 | 15.8 | 16.8 | 19.3 | ▲ 2.5 |
Key figures of Swedish Orphan Biovitrum (Belgium), fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Swedish Orphan Biovitrum (Belgium)?
What happened at Swedish Orphan Biovitrum (Belgium) in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 985,683 (▼ 21% vs 2024). Source: NBB ↗
- Filip Chavatte became a director. NBB
- Soufiane Fahmy became a director. NBB
- Torbjörn Hallberg became a director. NBB
- New establishment in Zaventem. KBO
- Start of the company according to the CBE. KBO
In short
From € 547,192 profit in 2022 to € 985,683 profit in 2025.
Paid € 1.5 million in corporate taxes since 2022.
Best year ever: 2024, with € 1.3 million profit.
Pays suppliers within 7 days on average.
A new publication or filing at Swedish Orphan Biovitrum (Belgium)? We notify you, reason included.
Follow Swedish Orphan Biovitrum (Belgium)Databakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Swedish Orphan Biovitrum (Belgium) are Soufiane Fahmy, Torbjörn Hallberg and Filip Chavatte. The shares are held by Swedish Orphan Biovitrum AB (publ) (100%).
Directors
According to the 2025 annual accounts
Soufiane Fahmy
Director
since 2018
Torbjörn Hallberg
Director
since 2018
Filip Chavatte
Managing director
since 2025
Shareholders
Swedish Orphan Biovitrum AB (publ)
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Hermeslaan 11
1932 Zaventem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
All companies at this address →L'Air liquide Belge
€ 126.7 million revenue · 2025
HYDROWAL
€ 1.8 million revenue · 2025
AIR LIQUIDE MEDICAL
€ 33.6 million revenue · 2025
SUMITOMO CHEMICAL EUROPE S.A./N.V.
€ 532.8 million revenue · 2025
AIR LIQUIDE INDUSTRIES BELGIUM
€ 573.8 million revenue · 2025
+12 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
AMAZON-02 - Amazon.com, Inc., US
Domain
Domain
sobi.com
Registered
2001-11-27
Registrar
Abion AB
Expires
2026-11-27
Website info
Features
Security
Details
- Company number
- 0536.217.087
- VAT number
- BE 0536.217.087
- Registered office
- Hermeslaan 11, 1932 Zaventem
- Names & denominations
- Swedish Orphan Biovitrum (Belgium)
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 June 2013
- Peppol
- Active · Active since 24 Nov 2025
- Contact
- sobi.com +4686972000
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen